This proposal requests funds for continued support of our comprehensive training program in molecular oncology and immunology. We request support to training 5 predoctoral and 10 postdoctoral fellows (PhD, MD or MD/PhD) in the integrated discipline of molecular oncology and immunology. Training focuses a combined education in this interdisciplinary area, to provide trainees with a better understanding of the regulatory mechanisms involved in cellular transformation, growth control, tumor initiation and progression, and immunological responses. A particular focus of the program is on translational approaches to improved cancer diagnosis and treatment. Cross-fertilization of these disciplines allows development of entirely new approaches to study both proto-oncogenes and immunologically relevant cells and tissues in their normal state as well as in neoplastic situations, fostering the development of translational research in cancer. The unique aspects of this program are that trainees become proficient in the basics of both immunology and molecular oncology;the students receive a significant exposure to cancer research in a clinical setting;the students have the opportunity for in-depth research on a cancer related project;the trainees become proficient in critical evaluation of the current literature, analysis of experimental data, and presentation of the results of research;and all trainees are educated in the responsible conduct of research. Thirty-nine faculty members from the Departments of Pathology, Cell Biology, Biochemistry, Pharmacology, Medicine, Pediatrics, Urology, Radiation Oncology, Dermatology, Radiology and Microbiology participate as primary mentors in this program, and they are supplemented with a committed set of clinician-educators as Associate Faculty. The program is under the aegis of the Sackler Institute for Basic Medical Sciences and the New York University Cancer Institute and makes full use of the extensive basic and clinical cancer research infrastructure of New York University School of Medicine to intimately involve trainees in both the practical and the intellectual rigors of cutting-edge cancer research.
The importance of actively recruiting the brightest minds into careers in cancer research and providing them with rigorous training in both fundamentals and practical approaches cannot be overestimated. Cancer incidence increases with the age of the population and will be a growing public health problem until comprehensive cures can be obtained, requiring a new cadre of investigators whose training is the purpose of this program.
|Dankert, John F; Rona, Gergely; Clijsters, Linda et al. (2016) Cyclin F-Mediated Degradation of SLBP Limits H2A.X Accumulation and Apoptosis upon Genotoxic Stress in G2. Mol Cell 64:507-519|
|Daniels, Garrett; Zhang, Xinmin; Zhong, Xuelin et al. (2016) Cytoplasmic, full length and novel cleaved variant, TBLR1 reduces apoptosis in prostate cancer under androgen deprivation. Oncotarget 7:39556-39571|
|Cantor, David J; David, Gregory (2016) The chromatin associated Sin3B protein is required for hematopoietic stem cell functions in mice. Blood :|
|Trimarchi, Thomas; Aifantis, Iannis (2015) The pre-BCR to the rescue: therapeutic targeting of pre-B cell ALL. Cancer Cell 27:321-3|
|Hanniford, Doug; Segura, Miguel F; Zhong, Judy et al. (2015) Identification of metastasis-suppressive microRNAs in primary melanoma. J Natl Cancer Inst 107:|
|Hanniford, Doug; Zhong, Judy; Koetz, Lisa et al. (2015) A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis. Clin Cancer Res 21:4903-12|
|Huang, Wendy; Thomas, Benjamin; Flynn, Ryan A et al. (2015) DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions. Nature 528:517-22|
|Pitt, Lauren A; Tikhonova, Anastasia N; Hu, Hai et al. (2015) CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance. Cancer Cell 27:755-68|
|Liang, Jiaqian; Li, Yirong; Daniels, Garrett et al. (2015) LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Mol Cancer Res 13:681-8|
|Young, Lauren M; Marzio, Antonio; Perez-Duran, Pablo et al. (2015) TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep 13:451-9|
Showing the most recent 10 out of 109 publications